PE/VC  Cavendish Impact Capital

https://www.cavendishimpactcapital.com/





     Office Locations:

6098 West Lake Rd
Cooperstown, NY 13326

 

Stages:

  • Early
  • Growth
  • Seed


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Cavendish Impact Capital operates in the sweet spot between Impact Venture Capital and Private Equity. Subscribers and co-investors of Cavendish include family offices, philanthropists and impact investors. Cavendish Impact Capital, and the targeted funds within it, will be managed by the current leadership of Global Bio Impact Fund under a license agreement with Cavendish Global. The firm's initial fund, The Cavendish Impact Capital Life Science Fund, will provide vital capital and a path to the marketplace for early-stage health and life science companies whose innovations have the potential to provide a transformational impact on disease prevention, diagnosis or treatment. Beyond the initial Life Science Fund, the leadership of Cavendish Impact Capital envisions future funds dedicated to provide meaningful impact on challenging issues across a spectrum of sectors. Typical investment size is 10% of total investment capital pool ($2.5-15MM).



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Jamison Feramisco MD, PhD Managing Partner & CMO
    John M. Evey Managing Partner
    Kelly J. McCrann Managing Partner & Chairman
    The Honorable William W. Nicholson Managing Partner
    Tony Quinones Managing Partner & CIO

     

    Portfolio companies include:


      Ciris Energy
        web link


      HaloGOODS
        web link


      Molecular Assemblies
        web link


      Purewater Therapeutics
        web link


      Vault Pharma
        web link


     

    Recent News: